Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Exercise of Warrants

4th Nov 2026 11:36

RNS Number : 8196B
Medpal AI PLC
04 November 2026
 

4 November 2026

MedPal AI plc

("MedPal" or the "Company")

Warrant Exercise

MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-powered, integrated digital health and pharmacy company, announces that the Company has received a notice to exercise warrants over a total of 1,570,000 new ordinary shares of 0.0002 pence each in the Company at an exercise price of 2.5 pence per share ("Warrant Shares"), raising £39,250 for the Company.

ADMISSION AND TOTAL VOTING RIGHTS

Application will be made for the 1,570,000 Warrant Shares to be admitted to trading on AIM which is expected to occur on or around 9 November 2026 ("Admission"). The Warrant Shares will rank pari passu in all respects with the ordinary shares of the Company currently traded on AIM.

Following Admission, the Company's issued share capital will comprise 891,519,135 ordinary shares of 0.0002p each. This number will represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please contact:

Enquiries:

MedPal AI plc

Jason Drummond, Chief Executive Officer

Via Square1 Consulting

Cairn Financial Advisers LLP (Nomad)

Louise O'Driscoll / Jo Turner

+44 (0) 20 7213 0880

Clear Capital Markets Limited

Bob Roberts

+44 (0) 20 3869 6080

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFSLFFLEMSEDF

Related Shares:

Medpal AI
FTSE 100 Latest
Value10,645.82
Change-44.05